标记免疫分析与临床2024,Vol.31Issue(4) :763-768,772.DOI:10.11748/bjmy.issn.1006-1703.2024.04.033

血清标志物在缺血性脑卒中应用中的研究进展

The Research Progress in the Application of Serum Markers in Ischemic Stroke

张钟丹 李云 张冬青
标记免疫分析与临床2024,Vol.31Issue(4) :763-768,772.DOI:10.11748/bjmy.issn.1006-1703.2024.04.033

血清标志物在缺血性脑卒中应用中的研究进展

The Research Progress in the Application of Serum Markers in Ischemic Stroke

张钟丹 1李云 2张冬青1
扫码查看

作者信息

  • 1. 中国人民解放军总医院第四医学中心检验科,北京 100048
  • 2. 中共中央办公厅警卫局卫生保健处,北京 100032
  • 折叠

摘要

缺血性脑卒中(ischemic stroke,IS)是脑卒中最常见的类型,致残率、致死率高,威胁人类健康.当前,血清标志物在缺血性脑卒中的应用,包括诊断和预后方面的研究,取得了一些进展.白细胞介素、NADPH氧化酶4、脂蛋白相关磷脂酶A2、可溶性细胞间黏附分子-1、基质金属蛋白酶等指标具有较好的诊断价值.随着基因组学、转录组学和蛋白组学等领域的迅速发展,非编码RNA的发现等为IS的病理生理学机制开辟了新的方向,有望成为IS诊断、治疗及预后相关的新型血清标志物.

Abstract

Ischemic stroke is the most common type of stroke,with high disability and fatality rates,threatening human health.Currently,the application of serum markers in ischemic stroke,including diagnosis and prognosis,has achieved some progresses.Interleukins,nicotinamide adenine dinucleotide phosphate oxidase,lipoprotein-associated phospholipase A2,soluble intercellular adhesion molecule,platelet activating factor,matrix metalloproteinase and other indicators have showed promising diagnostic values.With the rapid development of genomics,transcriptomics and proteomics research,the discovery of non-coding RNA has opened up novel directions for the pathophysiological mechanisms of ischemic stroke.NcRNA might serve as an important serum markers for the diagnosis,treatment and prognosis of ischemic stroke.

关键词

缺血性脑卒中/血清标志物/白细胞介素/血小板活化因子/非编码RNA

Key words

Ischemic stroke/Biological markers/Interleukins/Platelet activating factor/Noncoding RNA

引用本文复制引用

出版年

2024
标记免疫分析与临床
中国同辐股份有限公司

标记免疫分析与临床

CSTPCD
影响因子:0.978
ISSN:1006-1703
参考文献量7
段落导航相关论文